Twenty‐year outcome of prevalence, incidence, mortality and survival rate in patients with malignant bone tumors
Authors:
Top Cited Papers
- 19 August 2023
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 154 (2) , 226-240
Abstract
Malignant bone tumors are a group of rare malignant tumors and our study aimed to update the recent epidemiologic estimates based on the Surveillance, Epidemiology and End Results database. Patients diagnosed with malignant bone tumors from 2000 to 2019 were included and their characteristics were retrospectively described. The limited‐duration prevalence, annual age‐adjusted incidence and mortality were calculated, and the annual percentage changes were analyzed to quantify the rate change. Finally, observed survival and relative survival rate were illustrated. Subgroup analysis across tumor type, age, gender, tumor Grade, primary tumor site and stage was also performed. As for results, a total of 11 655 eligible patients with malignant bone tumor were selected. Osteosarcoma was the most common tumor type, followed by chondrosarcoma, Ewing sarcoma and chordoma. The estimated limited‐duration prevalence of malignant bone tumors increased from 2000 (0.00069%) to 2018 (0.00749%). Steady age‐adjusted incidence was observed in all patients during the study period while the highest rate occurred in osteosarcoma. Mortality rates differed in subgroups while elder patients (older than 64 years) presented the highest mortality rate compared to other age groups. In all bone tumors, the 10‐year observed survival and relative survival rates were 58.0% and 61.9%, respectively. Chondrosarcoma patients had the best survival outcome, followed by osteosarcoma, Ewing sarcoma, chordoma and other bone tumors. In conclusion, different epidemiologic performance in incidence and mortality was observed across tumor type as well as other demographic and clinicopathological variables, which provide potential suggestion for further adjustment of medical resource.Keywords
Funding Information
- National Natural Science Foundation of China (81872184)
This publication has 41 references indexed in Scilit:
- Incidence, Predictive Factors, and Prognosis of Chondrosarcoma in Patients with Ollier Disease and Maffucci Syndrome: An International Multicenter Study of 161 PatientsThe Oncologist, 2011
- Clinical features and outcomes in patients with extraskeletal ewing sarcomaCancer, 2011
- Genetic variation at chromosome 8q24 in osteosarcoma cases and controlsCarcinogenesis, 2010
- Osteosarcoma incidence and survival rates from 1973 to 2004Cancer, 2009
- Changes in Incidence and Survival of Ewing Sarcoma Patients Over the Past 3 DecadesJournal of Pediatric Hematology/Oncology, 2008
- Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-upAnnals of Oncology, 2008
- Osteosarcoma in Paget's Disease of BoneJournal of Bone and Mineral Research, 2006
- Pathology of primary malignant bone and cartilage tumoursInternational Orthopaedics, 2006
- [18F]Fluorodeoxyglucose Positron Emission Tomography Predicts Outcome for Ewing Sarcoma Family of TumorsJournal of Clinical Oncology, 2005
- Evaluation of chemotherapy response in pediatric bone sarcomas by [F‐18]‐fluorodeoxy‐D‐glucose positron emission tomographyCancer, 2002